Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1479 | 1417 | 0.0074 | 0.0082 | 0.9581 | 0.9545 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 726 | 696 | 0.0051 | 0.0054 | 0.9587 | 0.9547 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1444 | 1385 | 0.0070 | 0.0077 | 0.9591 | 0.9513 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1440 | 1382 | 0.0083 | 0.0084 | 0.9597 | 0.9531 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 921 | 884 | 0.0044 | 0.0047 | 0.9598 | 0.9535 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 937 | 901 | 0.0051 | 0.0064 | 0.9616 | 0.9579 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 422 | 406 | 0.0029 | 0.0041 | 0.9621 | 0.9488 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1090 | 1049 | 0.0059 | 0.0064 | 0.9624 | 0.9579 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 752 | 724 | 0.0047 | 0.0054 | 0.9628 | 0.9547 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 809 | 781 | 0.0033 | 0.0047 | 0.9654 | 0.9535 |